Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03307759
Title Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma (SABRseq)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia

lung non-small cell carcinoma



Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.